The Beauty Health Company (SKIN) Misses Q4 EPS by 10c, Revenue Beats, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
The Beauty Health Company (SKIN) PT Raised to $35 at DA Davidson
February 23, 2022 11:59 AM ESTDA Davidson analyst Linda Bolton Weiser raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $35.00 (from $32.00) while maintaining a Buy rating following results.
The analyst commented, "Although SKIN had pre-announced on January 10th that 4Q21 would be in line, it... More
